Raymond James Financial »

Adicet Bio shares owned by Raymond James Financial

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 13k 0.81
2025-06-30 $2.3k 3.8k 0.61

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Adicet Bio

OrbiMed Advisors
Tang Capital Management
RA Capital Management
Goldman Sachs Group
Vanguard Group
Carlyle
Acadian Asset Management
Renaissance Technologies
Regeneron Pharmaceuticals
Bridgeway Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Alyeska Investment Group
Rbf Capital

View all funds holding Adicet Bio